The kinetic stability of MHC class II:peptide complexes is a key parameter that dictates immunodominance.
暂无分享,去创建一个
Francisco A. Chaves | Christopher A. Lazarski | K. Richards | A. Sant | J. M. Weaver | Shenhong Wu | C. Lazarski | Shenhong Wu | Christopher A Lazarski | Francisco A Chaves | Scott A Jenks | Katherine A Richards | J M Weaver | Andrea J Sant | S. Jenks | Jason M. Weaver
[1] B. Evavold,et al. Modification of peptide interaction with MHC creates TCR partial agonists. , 2004, Cellular immunology.
[2] R. Locksley,et al. Expression cloning of a protective Leishmania antigen. , 1995, Science.
[3] L. Stern,et al. A three-step kinetic mechanism for peptide binding to MHC class II proteins. , 2000, Biochemistry.
[4] T. Hunkapiller,et al. Differential tolerance is induced in T cells recognizing distinct epitopes of myelin basic protein. , 1998, Immunity.
[5] N. Viner,et al. Destructive processing by asparagine endopeptidase limits presentation of a dominant T cell epitope in MBP , 2002, Nature Immunology.
[6] H. Mcconnell,et al. Kinetic intermediates in the reactions between peptides and proteins of major histocompatibility complex class II. , 1994, Proceedings of the National Academy of Sciences of the United States of America.
[7] B. Chain,et al. Protein degradation in MHC class II antigen presentation: opportunities for immunomodulation. , 2000, Seminars in Cell and Developmental Biology.
[8] E. Sercarz,et al. Cutting Edge: Introduction of an Endopeptidase Cleavage Motif into a Determinant Flanking Region of Hen Egg Lysozyme Results in Enhanced T Cell Determinant Display1 , 2000, The Journal of Immunology.
[9] D. Weber,et al. HLA-DM and the MHC class II antigen presentation pathway , 1999, Immunologic research.
[10] Philippa Marrack,et al. Epitope dominance, competition and T cell affinity maturation. , 2003, Current opinion in immunology.
[11] M. Vrljic,et al. Formation of a highly peptide-receptive state of class II MHC. , 1998, Immunity.
[12] G. Hämmerling,et al. Quality control of MHC class II associated peptides by HLA-DM/H2-M. , 1999, Seminars in immunology.
[13] A. Sant,et al. The inability of the nonobese diabetic class II molecule to form stable peptide complexes does not reflect a failure to interact productively with DM. , 1998, Journal of immunology.
[14] S. Stevanović,et al. Cathepsin G, and Not the Asparagine-Specific Endoprotease, Controls the Processing of Myelin Basic Protein in Lysosomes from Human B Lymphocytes1 , 2004, The Journal of Immunology.
[15] Paul V. Lehmann,et al. Endogenous Myelin Basic Protein Inactivates the High Avidity T Cell Repertoire , 1998, The Journal of experimental medicine.
[16] H. Grey,et al. Structural analysis of peptides capable of binding to more than one Ia antigen. , 1989, Journal of immunology.
[17] B. Evavold,et al. DO11.10 and OT-II T Cells Recognize a C-Terminal Ovalbumin 323–339 Epitope1 , 2000, The Journal of Immunology.
[18] R. Doebele,et al. Accessory molecules for MHC class II peptide loading. , 2000, Current opinion in immunology.
[19] Francisco A. Chaves,et al. Replacement of the membrane proximal region of I-A(d) MHC class II molecule with I-E-derived sequences promotes production of an active and stable soluble heterodimer without altering peptide-binding specificity. , 2005, Journal of immunological methods.
[20] Mark M Davis,et al. Continuous T cell receptor signaling required for synapse maintenance and full effector potential , 2003, Nature Immunology.
[21] A. Sant,et al. Invariant chain and DM edit self-peptide presentation by major histocompatibility complex (MHC) class II molecules , 1996, The Journal of experimental medicine.
[22] Ira Mellman,et al. Dendritic Cells Specialized and Regulated Antigen Processing Machines , 2001, Cell.
[23] H. Grey,et al. I-Ad-binding peptides derived from unrelated protein antigens share a common structural motif. , 1988, Journal of immunology.
[24] H. Mcconnell,et al. REACTIONS OF PEPTIDES WITH CLASS II PROTEINS OF THE MAJOR HISTOCOMPATIBILITY COMPLEX , 1995 .
[25] A Sette,et al. The Interaction between Protein‐Derived Immunogenic Peptides and Ia , 1987, Immunological reviews.
[26] R. Titus,et al. Higher frequency of Leishmania major-specific L3T4+ T cells in susceptible BALB/c as compared with resistant CBA mice. , 1986, Journal of immunology.
[27] A. Hill. The Combinations of Haemoglobin with Oxygen and with Carbon Monoxide. I. , 1913, The Biochemical journal.
[28] A. Khoruts,et al. In vivo activation of antigen-specific CD4 T cells. , 2001, Annual review of immunology.
[29] T. Mosmann,et al. In Vivo Priming of Cd4 T Cells That Produce Interleukin (Il)-2 but Not IL-4 or Interferon (Ifn)-γ, and Can Subsequently Differentiate into IL-4–Or IFN-γ–Secreting Cells , 2001, The Journal of experimental medicine.
[30] M. Coughlan,et al. Presentation of the Goodpasture Autoantigen to CD4 T Cells Is Influenced More by Processing Constraints Than by HLA Class II Peptide Binding Preferences* , 1998, The Journal of Biological Chemistry.
[31] A. Sant,et al. Cutting edge: a single, essential hydrogen bond controls the stability of peptide-MHC class II complexes. , 1999, Journal of immunology.
[32] Kevin E. Swier,et al. Control of Leishmania major by a monoclonal alpha beta T cell repertoire. , 1998, Journal of immunology.
[33] P. A. Peterson,et al. Crystal structures of two I-Ad-peptide complexes reveal that high affinity can be achieved without large anchor residues. , 1998, Immunity.
[34] S. Sadegh-Nasseri,et al. Stable peptide binding to MHC class II molecule is rapid and is determined by a receptive conformation shaped by prior association with low affinity peptides. , 1999, Journal of immunology.
[35] David L. Woodland,et al. The Majority of Immunogenic Epitopes Generate CD4+ T Cells That Are Dependent on MHC Class II-Bound Peptide-Flanking Residues1 , 2002, The Journal of Immunology.
[36] R. Phelps,et al. The Goodpasture antigen is expressed in the human thymus. , 2001, Kidney international.
[37] R. Locksley,et al. TH1 and TH2 cell antigen receptors in experimental leishmaniasis. , 1993, Science.
[38] A. Cope,et al. Relationship between kinetic stability and immunogenicity of HLA‐DR4/peptide complexes , 2002, European journal of immunology.
[39] H. Mcconnell,et al. A kinetic intermediate in the reaction of an antigenic peptide and I–Ek , 1989, Nature.
[40] T. Lybrand,et al. Ovalbumin(323-339) peptide binds to the major histocompatibility complex class II I-A(d) protein using two functionally distinct registers. , 1999, Biochemistry.
[41] A. Sant,et al. Dm Determines the Cryptic and Immunodominant Fate of T Cell Epitopes , 2000, The Journal of experimental medicine.
[42] G. Hämmerling,et al. How HLA-DM edits the MHC class II peptide repertoire: survival of the fittest? , 1997, Immunology today.
[43] H. Mcdevitt,et al. A role for non-MHC genetic polymorphism in susceptibility to spontaneous autoimmunity. , 1994, Immunity.
[44] A. Taylor,et al. Identification of eight determinants in the hemagglutinin molecule of influenza virus A/PR/8/34 (H1N1) which are recognized by class II-restricted T cells from BALB/c mice , 1991, Journal of virology.
[45] M. Hofnung,et al. Expression of heterologous peptides at two permissive sites of the MalE protein: antigenicity and immunogenicity of foreign B-cell and T-cell epitopes. , 1992, Gene.
[46] J. Blum,et al. Antigen-presenting cells and the selection of immunodominant epitopes. , 1997, Critical reviews in immunology.
[47] K. Wucherpfennig,et al. Structural Factors Contributing to DM Susceptibility of MHC Class II/Peptide Complexes1 , 2002, The Journal of Immunology.
[48] Ronald N Germain,et al. In vivo antigen presentation. , 2004, Current opinion in immunology.
[49] D. Kioussis,et al. Low avidity recognition of self-antigen by T cells permits escape from central tolerance. , 1995, Immunity.
[50] Francisco A. Chaves,et al. The relationship between immunodominance, DM editing, and the kinetic stability of MHC class II:peptide complexes , 2005, Immunological reviews.
[51] R. Locksley,et al. Rapid expansion and IL-4 expression by Leishmania-specific naive helper T cells in vivo. , 2002, Immunity.
[52] F. Sallusto,et al. Antigen decoding by T lymphocytes: from synapses to fate determination , 2001, Nature Immunology.
[53] A. Miller,et al. Dominance and crypticity of T cell antigenic determinants. , 1993, Annual review of immunology.
[54] E. Sercarz,et al. Immunodominance is independent of structural constraints: each region within hen eggwhite lysozyme is potentially available upon processing of native antigen. , 1997, Journal of immunology.
[55] S. Sadegh-Nasseri,et al. The Magnitude of TCR Engagement Is a Critical Predictor of T Cell Anergy or Activation1 , 2004, The Journal of Immunology.